Sarepta Therapeutics, Inc.SRPTNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-56.1%
5Y CAGR-47.0%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-56.1%/yr
vs -15.6%/yr prior
5Y CAGR
-47.0%/yr
Recent deceleration
Acceleration
-40.5pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.03 | -83.1% |
| 2024 | 6.08 | -15.2% |
| 2023 | 7.17 | -41.1% |
| 2022 | 12.16 | +16.6% |
| 2021 | 10.43 | -57.6% |
| 2020 | 24.61 | -1.3% |
| 2019 | 24.94 | +3.9% |
| 2018 | 24.02 | +13.4% |
| 2017 | 21.17 | -91.4% |
| 2016 | 246.33 | - |